NFKB1 and type 2 diabetes mellitus: The results of the present study indicated that ALA may inhibit the expression of NF‐κB, suppressing the activation of the NLRP3 inflammasome, and subsequently reducing cytokine production and inflammatory responses in the livers of T2DM model rats.